The Brexit Health Alliance is warning that efforts to prevent the spread of infectious diseases in the UK could be under threat if the country pulls out of the EU’s early warning system without having a suitable replacement.
The NHS could free up frontline time worth up to £12.5 billion a year by fully embracing automation, such as employing robots at the bed side and care bots in the home, according to a new report led by former health minister Lord Darzi.
The Scottish Medicines Consortium has approved NHS funding for six new therapies, offering patients new options for leukaemia, epilepsy, lung cancer, plaque psoriasis, and carcinoid syndrome-related diarrhea.
An international team of researchers, led by scientists at The Institute of Cancer Research, London, are planning to trial a novel saliva-based DNA test designed to predict men at risk of developing prostate cancer.
US regulators have approved a combination of AbbVie and Roche’s Venclexta in combination with Roche/Biogen's Rituxan (rituximab) to treat chronic lymphocytic leukaemia (CLL) or small lymphocytic lymphoma (SLL).
Following on from Dr Jim Golby’s comments only last week, David Garmon-Jones, co-chair of the competition’s executive steering group (ESG) is also calling on all pharma sales professionals to get involved in the competition.